- Akwai alamun farkon cewa jabs na iya hana watsa Delta.
- Duk alluran riga -kafi da ake amfani da su a Burtaniya na buƙatar masu karɓa su karɓi allurai biyu don yin cikakken allurar.
- Kimanin kashi 75 cikin XNUMX na yawan mutanen Burtaniya sun sami harbi biyu har zuwa yau.
A cikin sabon sabuntawar coronavirus, Harkokin Kiwon Lafiyar Jama'a Ingila (HAU) yayi gargadin game da alamun farko da ke nuna cewa mutanen da aka yiwa allurar rigakafin na iya samun damar watsa bambancin Delta na COVID-19 cikin sauƙi kamar waɗanda ba su sami harbi ba.
Dangane da sakin PHE, daruruwan mutane masu cikakken allurar rigakafi a Burtaniya an kwantar da su a asibiti tare da bambance-bambancen Delta COVID-19.
Daga 19 ga Yuli zuwa 2 ga Agusta, 55.1% na mutane 1,467 da ke asibiti tare da bambancin Delta ba a yi musu allurar rigakafi ba, in ji PHE, yayin da kashi 34.9% - ko kuma mutane 512 - suka sami allurai biyu.
Yuli 19 ita ce ranar da aka sauƙaƙe ƙuntatawa ƙulli a Burtaniya.
Duk alluran rigakafin da ake amfani da su a Burtaniya-waɗanda AstraZeneca, Moderna da Pfizer-BioNTech suka samar-suna buƙatar masu karɓa su karɓi allurai biyu don yin cikakken allurar.
Kimanin kashi 75 cikin XNUMX na yawan mutanen Burtaniya sun sami harbi biyu har zuwa yau.
"Yayin da yawancin jama'a ke yin allurar rigakafin, za mu ga mafi yawan adadin mutanen da aka yiwa allurar a asibiti," in ji PHE.
Jenny Harries, babban jami'in Hukumar Tsaron Kiwon Lafiya ta Burtaniya, ya ce alkaluman asibiti sun nuna "sake yadda yake da mahimmanci mu duka mu fito don karbar allurar rigakafin duka da zaran mun sami damar yin hakan".
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- Jenny Harries, babban jami'in Hukumar Tsaron Kiwon Lafiya ta Burtaniya, ya ce alkaluman asibiti sun nuna "sake yadda yake da mahimmanci mu duka mu fito don karbar allurar rigakafin duka da zaran mun sami damar yin hakan".
- A cikin sabuwar sabuntawa ta coronavirus, Kiwon Lafiyar Jama'a Ingila (PHE) yayi gargadi game da alamun farko cewa mutanen da aka yiwa alurar riga kafi na iya yada bambancin Delta na COVID-19 cikin sauƙi kamar waɗanda ba su sami wani harbi ba.
- Duk alluran rigakafin da ake amfani da su a Burtaniya-waɗanda AstraZeneca, Moderna da Pfizer-BioNTech suka samar-suna buƙatar masu karɓa su karɓi allurai biyu don yin cikakken allurar.
